Trials / Sponsors / Oncovir, Inc.
Oncovir, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults COVID - 19 | Phase 1 | 2021-07-21 |
| Completed | Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma | Phase 1 | 2020-08-19 |
| Terminated | Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 Solid Cancer | Phase 1 / Phase 2 | 2018-09-25 |
| Completed | In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® Melanoma, Head and Neck Cancer, Sarcoma | Phase 2 | 2015-03-01 |